📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Valerion Therapeutics

1.1 - Company Overview

Valerion Therapeutics Logo

Valerion Therapeutics

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of therapies for orphan genetic muscle diseases utilizing a novel antibody-based targeting system.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Valerion Therapeutics

Intrommune Therapeutics Logo

Intrommune Therapeutics

HQ: United States Website
  • Description: Provider of biotechnology, based in New York.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Intrommune Therapeutics company profile →
Adaptate Biotherapeutics Logo

Adaptate Biotherapeutics

HQ: Canada Website
  • Description: Provider of antibodies designed to modulate gamma delta T cells in situ.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Adaptate Biotherapeutics company profile →
NextCure Logo

NextCure

HQ: United States Website
  • Description: Provider of biopharmaceutical discovery and development focused on next-generation immuno-oncology-based drugs.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full NextCure company profile →
OncoPep Logo

OncoPep

HQ: United States Website
  • Description: Provider of investigational multi-peptide therapeutic cancer vaccines and adoptive T cell therapies, including PVX-410 for patients with triple negative breast cancer (TNBC) and asymptomatic multiple myeloma (MM)/smoldering multiple myeloma (SMM); MTAA-420 for multiple myeloma; and second-generation vaccines PVX-024/PVX-510 to enhance the first iteration of OncoPep's vaccine and expand to additional HLA subtypes, such as HLA-A24.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full OncoPep company profile →
Synthon Logo

Synthon

HQ: The Netherlands Website
  • Description: Provider of affordable generic medicines and pharmaceutical development and manufacturing services, including API development, formulation development (solid oral dose, immediate and modified release, injectables), high-containment compounds for cancer treatment, R&D across multiple countries, and global manufacturing of tablets, capsules, and injectables.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Synthon company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Valerion Therapeutics

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Valerion Therapeutics

2.2 - Growth funds investing in similar companies to Valerion Therapeutics

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Valerion Therapeutics

4.2 - Public trading comparable groups for Valerion Therapeutics

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Valerion Therapeutics

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Valerion Therapeutics

What does Valerion Therapeutics do?

Valerion Therapeutics is a provider of therapies for orphan genetic muscle diseases utilizing a novel antibody-based targeting system.

Who are Valerion Therapeutics's competitors?

Valerion Therapeutics's competitors and similar companies include Intrommune Therapeutics, Adaptate Biotherapeutics, NextCure, OncoPep, and Synthon.

Where is Valerion Therapeutics headquartered?

Valerion Therapeutics is headquartered in United States.

How many employees does Valerion Therapeutics have?

Valerion Therapeutics has 1,000 employees 🔒.

When was Valerion Therapeutics founded?

Valerion Therapeutics was founded in 2010 🔒.

What sector and industry vertical is Valerion Therapeutics in?

Valerion Therapeutics is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Valerion Therapeutics

Who are the top strategic acquirers in Valerion Therapeutics's sector and industry

Top strategic M&A buyers and acquirers in Valerion Therapeutics's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Valerion Therapeutics?

Top strategic M&A buyers groups and sectors for Valerion Therapeutics include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Valerion Therapeutics's sector and industry vertical

Which are the top PE firms investing in Valerion Therapeutics's sector and industry vertical?

Top PE firms investing in Valerion Therapeutics's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Valerion Therapeutics's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Valerion Therapeutics's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Valerion Therapeutics's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Valerion Therapeutics include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Valerion Therapeutics's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Valerion Therapeutics?

The key public trading comparables and valuation benchmarks for Valerion Therapeutics include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Valerion Therapeutics for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Valerion Therapeutics with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Valerion Therapeutics's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Valerion Therapeutics with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Valerion Therapeutics's' sector and industry vertical?

Access recent funding rounds and capital raises in Valerion Therapeutics's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Valerion Therapeutics